Glaxosmithkline Plc Adr Stock Return On Equity

GSK Stock  USD 43.13  0.14  0.33%   
GlaxoSmithKline PLC ADR fundamentals help investors to digest information that contributes to GlaxoSmithKline PLC's financial success or failures. It also enables traders to predict the movement of GlaxoSmithKline Stock. The fundamental analysis module provides a way to measure GlaxoSmithKline PLC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GlaxoSmithKline PLC stock.
Return On Equity is expected to rise to 0.42 this year.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

GlaxoSmithKline Return On Equity Analysis

GlaxoSmithKline PLC's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

GlaxoSmithKline PLC Return On Equity

0.42

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current GlaxoSmithKline PLC Return On Equity

    
  0.46  
Most of GlaxoSmithKline PLC's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GlaxoSmithKline PLC ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

GlaxoSmithKline Return On Equity Driver Correlations

Understanding the fundamental principles of building solid financial models for GlaxoSmithKline PLC is extremely important. It helps to project a fair market value of GlaxoSmithKline Stock properly, considering its historical fundamentals such as Return On Equity. Since GlaxoSmithKline PLC's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of GlaxoSmithKline PLC's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of GlaxoSmithKline PLC's interrelated accounts and indicators.
-0.320.50.90.77-0.070.770.970.910.710.70.120.940.120.50.95-0.11-0.160.230.450.56-0.260.57-0.590.590.40.490.5-0.250.2
-0.320.29-0.36-0.590.31-0.3-0.36-0.06-0.380.220.26-0.420.170.11-0.29-0.150.06-0.57-0.03-0.25-0.020.030.11-0.110.26-0.130.050.52-0.7
0.50.290.430.10.390.040.310.480.250.330.880.51-0.10.380.68-0.65-0.230.10.520.690.060.75-0.270.780.70.420.820.35-0.44
0.9-0.360.430.7-0.090.740.890.820.90.650.080.82-0.080.640.84-0.020.020.20.380.5-0.050.47-0.490.650.320.580.5-0.260.24
0.77-0.590.10.7-0.10.780.820.670.590.53-0.230.740.00.350.690.22-0.060.310.260.39-0.150.39-0.510.270.080.130.24-0.220.37
-0.070.310.39-0.09-0.1-0.22-0.090.13-0.090.00.42-0.18-0.14-0.240.03-0.06-0.510.180.580.390.210.54-0.270.110.67-0.190.610.39-0.51
0.77-0.30.040.740.78-0.220.850.80.590.78-0.40.640.290.630.590.410.17-0.130.050.04-0.350.12-0.520.12-0.050.10.06-0.30.38
0.97-0.360.310.890.82-0.090.850.910.750.74-0.110.880.140.470.860.08-0.150.230.410.45-0.270.48-0.630.460.330.420.4-0.290.25
0.91-0.060.480.820.670.130.80.910.650.880.060.720.140.60.790.14-0.04-0.040.440.4-0.20.48-0.540.410.410.310.47-0.210.13
0.71-0.380.250.90.59-0.090.590.750.650.55-0.030.65-0.250.560.660.120.120.250.310.420.140.34-0.310.550.190.530.37-0.180.21
0.70.220.330.650.530.00.780.740.880.55-0.140.490.150.740.550.280.23-0.330.210.1-0.160.25-0.40.180.210.140.21-0.01-0.02
0.120.260.880.08-0.230.42-0.4-0.110.06-0.03-0.140.2-0.220.030.37-0.78-0.290.180.430.630.20.60.020.660.60.320.70.34-0.44
0.94-0.420.510.820.74-0.180.640.880.720.650.490.20.140.380.96-0.33-0.260.40.370.61-0.310.61-0.570.70.350.570.51-0.130.14
0.120.17-0.1-0.080.0-0.140.290.140.14-0.250.15-0.220.14-0.110.020.15-0.29-0.35-0.39-0.45-0.98-0.13-0.17-0.14-0.18-0.09-0.18-0.040.06
0.50.110.380.640.35-0.240.630.470.60.560.740.030.38-0.110.440.130.65-0.46-0.10.020.10.03-0.060.29-0.080.250.12-0.040.13
0.95-0.290.680.840.690.030.590.860.790.660.550.370.960.020.44-0.38-0.260.360.510.73-0.170.73-0.580.760.520.560.67-0.050.03
-0.11-0.15-0.65-0.020.22-0.060.410.080.140.120.28-0.78-0.330.150.13-0.380.38-0.4-0.32-0.59-0.07-0.580.14-0.66-0.53-0.49-0.52-0.370.49
-0.160.06-0.230.02-0.06-0.510.17-0.15-0.040.120.23-0.29-0.26-0.290.65-0.260.38-0.65-0.54-0.460.35-0.640.54-0.34-0.65-0.17-0.56-0.250.39
0.23-0.570.10.20.310.18-0.130.23-0.040.25-0.330.180.4-0.35-0.460.36-0.4-0.650.570.70.210.57-0.420.460.450.350.490.09-0.12
0.45-0.030.520.380.260.580.050.410.440.310.210.430.37-0.39-0.10.51-0.32-0.540.570.840.340.75-0.540.430.870.150.720.07-0.31
0.56-0.250.690.50.390.390.040.450.40.420.10.630.61-0.450.020.73-0.59-0.460.70.840.330.85-0.410.720.770.40.810.11-0.23
-0.26-0.020.06-0.05-0.150.21-0.35-0.27-0.20.14-0.160.2-0.31-0.980.1-0.17-0.070.350.210.340.330.040.240.010.15-0.040.120.1-0.13
0.570.030.750.470.390.540.120.480.480.340.250.60.61-0.130.030.73-0.58-0.640.570.750.850.04-0.650.760.880.450.920.41-0.52
-0.590.11-0.27-0.49-0.51-0.27-0.52-0.63-0.54-0.31-0.40.02-0.57-0.17-0.06-0.580.140.54-0.42-0.54-0.410.24-0.65-0.4-0.56-0.25-0.53-0.160.24
0.59-0.110.780.650.270.110.120.460.410.550.180.660.7-0.140.290.76-0.66-0.340.460.430.720.010.76-0.40.60.810.830.25-0.29
0.40.260.70.320.080.67-0.050.330.410.190.210.60.35-0.18-0.080.52-0.53-0.650.450.870.770.150.88-0.560.60.360.870.31-0.59
0.49-0.130.420.580.13-0.190.10.420.310.530.140.320.57-0.090.250.56-0.49-0.170.350.150.4-0.040.45-0.250.810.360.52-0.01-0.1
0.50.050.820.50.240.610.060.40.470.370.210.70.51-0.180.120.67-0.52-0.560.490.720.810.120.92-0.530.830.870.520.36-0.47
-0.250.520.35-0.26-0.220.39-0.3-0.29-0.21-0.18-0.010.34-0.13-0.04-0.04-0.05-0.37-0.250.090.070.110.10.41-0.160.250.31-0.010.36-0.9
0.2-0.7-0.440.240.37-0.510.380.250.130.21-0.02-0.440.140.060.130.030.490.39-0.12-0.31-0.23-0.13-0.520.24-0.29-0.59-0.1-0.47-0.9
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

GlaxoSmithKline Total Stockholder Equity

Total Stockholder Equity

14.01 Billion

At this time, GlaxoSmithKline PLC's Total Stockholder Equity is quite stable compared to the past year.
Based on the latest financial disclosure, GlaxoSmithKline PLC ADR has a Return On Equity of 0.4638. This is 101.93% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The return on equity for all United States stocks is notably lower than that of the firm.

GlaxoSmithKline Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GlaxoSmithKline PLC's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GlaxoSmithKline PLC could also be used in its relative valuation, which is a method of valuing GlaxoSmithKline PLC by comparing valuation metrics of similar companies.
GlaxoSmithKline PLC is currently under evaluation in return on equity category among related companies.

GlaxoSmithKline Fundamentals

About GlaxoSmithKline PLC Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze GlaxoSmithKline PLC ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GlaxoSmithKline PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GlaxoSmithKline PLC ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Return On Equity 0.37  0.42 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether GlaxoSmithKline PLC ADR is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if GlaxoSmithKline Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Glaxosmithkline Plc Adr Stock. Highlighted below are key reports to facilitate an investment decision about Glaxosmithkline Plc Adr Stock:

Complementary Tools for GlaxoSmithKline Stock analysis

When running GlaxoSmithKline PLC's price analysis, check to measure GlaxoSmithKline PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline PLC is operating at the current time. Most of GlaxoSmithKline PLC's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline PLC's price. Additionally, you may evaluate how the addition of GlaxoSmithKline PLC to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Valuation
Check real value of public entities based on technical and fundamental data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Is GlaxoSmithKline PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Dividend Share
0.58
Earnings Share
3.02
Revenue Per Share
14.97
Quarterly Revenue Growth
0.092
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.